跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,262 条关于
“kappa light chain amyloidosis”
全部
8,262
临床试验
5,027
药物
282
机构
79
资讯
2,874
3个月前
AstraZeneca's Anselamimab Shows 62% Survival Improvement in Kappa Light Chain Amyloidosis Despite Missing Primary Endpoint
去年
Immix Biopharma's NXC-201 Advances to Expansion Cohort in US AL Amyloidosis Trial
2年前
FDA Grants Orphan Drug Designation to Immix Biopharma's NXC-201 for AL Amyloidosis
去年
FDA Clears Roche's VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail for B-Cell Lymphoma Diagnosis
3个月前
Attralus' Zamubafusp Alfa Receives FDA Orphan Drug Designation for AL Amyloidosis
去年
Serum Neurofilament Light Chain Shows Potential as Fabry Disease Biomarker
去年
AstraZeneca's Anselamimab Fails Primary Endpoint in Phase III AL Amyloidosis Trial, Shows Promise in Patient Subgroup
9个月前
Protego Biopharma Raises $130M to Advance Novel Protein Stabilization Approach for AL Amyloidosis
去年
FDA Grants Fast Track Designation to [18F]Florbetaben for Cardiac Amyloidosis Diagnosis
3年前
Nexcella's NXC-201 CAR-T Therapy Shows 100% Response in Darzalex-Relapsed AL Amyloidosis
第 1 页，共 288 页
上一页
下一页
